V1377

Vinblastine sulfate salt

≥97% (HPLC), powder, plant alkaloid

• Synonyme(s) : VLB, Vincaleukoblastine sulfate salt
• Formule empirique (notation de Hill): C₄₆H₅₈N₄O₉ · H₂SO₄
• Numéro CAS: 143-67-9
• Poids moléculaire : 909.05
• Numéro Beilstein : 3659812
• Numéro CE : 205-606-0
• Numéro MDL: MFCD00082457
• Code UNSPSC : 12352200
• ID de substance PubChem : 24278771
• Nomenclature NACRES : NA.77

Propriétés

• product name: Vinblastine sulfate salt, ≥97% (HPLC)
• Niveau de qualité: 200
• Pureté: ≥97% (HPLC)
• Forme: (powder or amorphous or crystalline powder)
• Couleur: white to light yellow
• Pf: 267 °C (dec.) (lit.)
• Absorption: 14 at 270 nm in 0.1 M phosphate buffer at 1 mM; 16.2 at 259 nm in ethanol at 1 mM; 53.7 at 214 nm in ethanol at 1 mM
• Spectre d'activité de l'antibiotique: neoplastics
• Mode d’action: DNA synthesis | interferes
• Auteur: Eli Lilly
• Température de stockage: 2-8°C
• Chaîne SMILES: OS(O)(=O)=O.[H][C@@]12CN(CCc3c([nH]c4ccccc34)[C@@](C1)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@@]7([H])[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@]89[H])C(=O)OC)C[C@](O)(CC)C2
• InChI: 1S/C46H58N4O9.H2O4S/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7;1-5(2,3)4/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3;(H2,1,2,3,4)/t28-,37-,38+,39+,42-,43+,44+,45-,46-;/m0./s1
• Clé InChI: KDQAABAKXDWYSZ-PNYVAJAMSA-N
• Informations sur le gène: human ... TBCC(6903) , TUBA1A(7846) , TUBA1B(10376) , TUBA1C(84790) , TUBA3C(7278) , TUBA3E(112714) , TUBA4A(7277) , TUBB(203068) , TUBB1(81027) , TUBB2A(7280) , TUBB2B(347733) , TUBB3(10381) , TUBB4A(10382) , TUBB4B(10383) , TUBB6(84617) , TUBB8(347688)

Description

Application

Vinblastine sulfate salt has been used:

• as a microtubule depolymerizing drug for the synchronization of human cell lines in G2/M phase
• as a multidrug resistance screening substrate in human colon cancer cell line (HCT116) cell line
• as an antimicrotubule agent in sub perineural glia of Drosophila brain

Actions biochimiques/physiologiques

Plant alkaloid that inhibits microtubule assembly by binding tubulin and inducing self-association in spiral aggregates in a reaction that appears to be regulated by the C-terminus of β-tubulin and is enhanced by GDP and GTP. Depolymerizes microtubules. Arrests the cell cycle in G2/M-phase by blocking mitotic spindle formation. Triggers Raf-1 activation, phosphorylation of bcl-2-family proteins, induction of p53 expression, and apoptosis in several tumor cell lines. Substrate of Pgp and CYP3A4.

Caractéristiques et avantages

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Eli Lilly. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Informations sur la sécurité

• Pictogrammes: GHS08,GHS07
• Mention d'avertissement: Warning
• Mentions de danger: H302,H341,H361fd
• Conseils de prudence: P201 - P301 + P312 + P330 - P308 + P313
• Classification des risques: Acute Tox. 4 Oral - Muta. 2 - Repr. 2
• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3